Digital Pharmaceuticals: How AI and VR Technologies Are Transforming the Pharmaceutical Industry

Born in Moscow, Russia on 27 November 1968.
Ignatiev holds an MD – diploma with honours from the I.M. Sechenov First Moscow State Medical University. Expert in clinical pharmacology. Holds a Candidate of Medical Research Degree. Studied at Columbia University College of Physicians and Surgeons (New York, USA). Holds MBA degrees from Moscow International Higher Business School MIRBIS and London Guildhall University (now part of the London Metropolitan University).
For 7 years Ignatiev worked in the Russian branch of the international pharmaceutical company Bristol-Myers Squibb in the positions of Product Manager, Franchise Manager, Marketing Director.
For 5 years Ignatiev served in the Russian branch of the international pharmaceutical company AstraZeneca in the leading positions of Marketing Director and Sales Director.
In 2008, Ignatiev was appointed Director for Business Development in CJSC R-Pharm, a Russian pharmaceutical company. And now he is the Chief Executive Officer.
In 2018 Ignatiev was elected to become Vice Chair of the Board of the Association of International Pharmaceutical Manufacturers.

Shestakov, Vladislav (born on November 27, 1969, in Salekhard, USSR) is a Director of State Institute of Drugs and Good Practices, Deputy Director of Russian State GMP-Inspectorate.
Before being appointed as a Director of the Institute served as Chairman of the Pharmacy and Biotechnology branch offices of All Russia Public Organization “Business Russia”.
Honorary chemist, a certified inspector and GMP auditor. Russian State GMP-Inspectorate Deputy Head and Head of the GP Committee of the Pharmacy vocational qualifications Council of the National Pharmaceutical Chamber. Since 1997 has been working in the field of healthcare and pharmacy.
Biography
Born on November 27, 1969 in Salekhard, Yamalo-Nenets Autonomous area, USSR. In 1987 he entered the Tyumen State Medical Institute, in 1989 he continued his studies at the Smolensk State Medical Academy. He graduated from the State University of Management (2005), specialty – “State and municipal management”. In 2008 he graduated from the Academy of Labor and Social Relations, “Business Administration”. In 2016 he got a vocational retraining diploma of the Moscow Institute of Physics and Technology (MIPT), "GMP and drugs quality control - theory and practice of GMP-inspection / audit."
2000 - Deputy Director-General, Irbitsky Chemical and Pharmaceutical Plant.
2001-2001 - Vice-president, Rosmedprom.
2002-2003 - Head of commercial department, Hemofarm, Moscow office.
2004-2005 - Deputy Director-General, Makiz-Pharma.
2005 - General Director, Skopinsky Pharmaceutical Plant.
2007 – GR Director, Union of Professional Pharmaceutical Organizations.
2008 – President, Epidbiomed Group of Companies.
2009 - Business Development Director, Binnopharm.
2011-2012 – Counselor to the Director-General, Usolie-Sibirskiy Khimfarmzavod.
2012-2013 – Deputy Director-General, Nanolek.

On November 27, 2013, Shestakov was appointed as Director of State Institute of Drugs and Good Practices.
Since 2003, he has been a regular lecturer of educational programs for professional development in the field of managing the commercial and government organizations’ activities, as well as specialized programs in pharmaceuticals and pharmaceutical production. He has the certificate of the international inspector of WHO on good manufacturing practice.
Awards
• The title of “Honorary Chemist”
• Certificate of Honor from the Minister of Industry and Trade of the Russian Federation “For achieved progress at work”.